![Amicus Therapeutics, Inc. [FOLD] to Ring The NASDAQ Stock Market Closing Bell](https://www.pompecanada.com/wp-content/uploads/2014/03/press-release-1080x400.jpg)
Amicus Therapeutics, Inc., a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, will visit the NASDAQ MarketSite in Times Square in celebration of Rare Disease Day® 2014.
28 February, 2014 marks the seventh international Rare Disease Day coordinated by EURORDIS. On and around this day hundreds of patient organisations from more than 70 countries and regions worldwide are planning awareness-raising activities around the slogan “Join Together for Better Care”.
Happy Rare Disease Day everyone! That does seem like an odd thing to say, but we celebrate the things that define our lives and for those of us that have a rare disease, it certainly plays a significant part in it.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced its support of International Rare Disease Day with a series of events to celebrate and recognize the global rare disease community.
The Dutch Rare Disease Day was celebrated in Amsterdam. A big surprise was planned for all participants. The Dutch Genzyme team, in close collaboration with the organizing committee, had organized an unannounced spectacular end to the meeting!
Genzyme Corporation (NASDAQ: GENZ) today recognized International Rare Disease Day with the launch of a new program, the Genzyme Patient Advocacy Leadership Awards (PAL Awards).
Mr. Speaker, some 2.7 million Canadians are affected by 1 in 6,000 rare disorders, such as cystic fibrosis, sickle cell disease and thalassemia. Most rare disorders are difficult to diagnose and are chronic, degenerative, progressive and life-threatening.